19-35269470-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003367.4(USF2):c.87G>T(p.Glu29Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000367 in 1,550,580 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003367.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USF2 | NM_003367.4 | c.87G>T | p.Glu29Asp | missense_variant | 2/10 | ENST00000222305.8 | NP_003358.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USF2 | ENST00000222305.8 | c.87G>T | p.Glu29Asp | missense_variant | 2/10 | 1 | NM_003367.4 | ENSP00000222305.2 |
Frequencies
GnomAD3 genomes AF: 0.000199 AC: 30AN: 150742Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.000160 AC: 28AN: 174692Hom.: 0 AF XY: 0.000154 AC XY: 15AN XY: 97522
GnomAD4 exome AF: 0.000385 AC: 539AN: 1399838Hom.: 1 Cov.: 33 AF XY: 0.000367 AC XY: 255AN XY: 695108
GnomAD4 genome AF: 0.000199 AC: 30AN: 150742Hom.: 0 Cov.: 28 AF XY: 0.000190 AC XY: 14AN XY: 73592
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.87G>T (p.E29D) alteration is located in exon 2 (coding exon 2) of the USF2 gene. This alteration results from a G to T substitution at nucleotide position 87, causing the glutamic acid (E) at amino acid position 29 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at